Clinical Trials Browser

Hodgkin Disease × tislelizumab × 1 year × Clear all

NCT05502250 2026-03-06

HOVON164HL

Phase 2 Active not recruiting

Hodgkin Disease

NCT05977673 2025-12-08

FIL_Tisle-HL

Phase 2 Recruiting

Hodgkin Disease, Lymphoma